Joshua Mahony MSTA
Scope Markets
The Brexit bill has been approved in Parliament, eradicating fears of a no-deal Brexit. While the AstraZeneca vaccine gives hope of a ramp-up in vaccinations, near-term lockdown measures and an impending exit from the EU is hurting sentiment.
- UK stocks ease back despite passing of Brexit bill
- Brexit fears and tightening restrictions dampen sentiment
- AstraZeneca vaccine approval helps improve outlook for 2021 recovery
UK stocks are on the back foot despite the passing of the Brexit Bill, putting to bed fears of a no-deal Brexit when the UK leaves the EU on Thursday night. Unfortunately it appears to be the case of a buy-the-rumour, sell-the-fact scenario. Despite allaying fears of a no-deal scenario, we are instead facing up to the fact that the UK is facing months of economic instability. With the government shifting a further 20 million people into Tier 4 tomorrow, 78% of the country will be operating under restrictions that severely hinder economic activity. With a record 53,000 new cases yesterday, the UK remains on a sharp upward trajectory with no sign of turning the corner. The fear is that without a swift reversal in cases, there is a strong chance that the government either lengthens or tightens restrictions further.
The outlook for 2021 looks positive given today’s UK approval of the crucial AstraZeneca/Oxford vaccine. With the government having ordered 100 million doses of the cheap and easily stored product, there is a hope we will see a sharp ramp-up in vaccinations in the months ahead. While the vaccine requires two-doses for long-term protection, the ability to substantially shield patients with the first jab allows for a huge initial roll-out in the UK. Much of 2021 will be dominated by a perception of just how swiftly we can remove restrictions and allow businesses to get back to some semblance of normality. The rollout will be heavily influenced by just how quickly the government can obtain the product. With both Pfizer and AstraZeneca products now available for the NHS to administer, we are looking at a dramatic ramp-up in the speed to inoculation throughout the UK.
This material is a marketing communication and shall not in any case be construed as an investment advice, investment recommendation or presentation of an investment strategy. The marketing communication is prepared without taking into consideration the individual investors personal circumstances, investment experience or current financial situation. Any information contained therein in regards to past performance or future forecasts does not constitute a reliable indicator of future performance, as circumstances may change over time. Scope Markets shall not accept any responsibility for any losses of investors due to the use and the content of the abovementioned information. Please note that forex trading and trading in other leveraged products involves a significant level of risk and is not suitable for all investors.
Recommended Content
Editors’ Picks
EUR/USD declines toward 1.0850 after US data
EUR/USD extends its downward correction toward 1.0850 in the American session. The US Department of Labor reported that there were 222,000 first-time application for unemployment benefits last week, helping the USD hold its ground and causing the pair to stretch lower.
GBP/USD corrects to 1.2650 area on modest USD recovery
After touching its highest level in over a month at 1.2700, GBP/USD reversed its direction and declined toward 1.2650 on Thursday. The modest USD rebound seen following Wednesday's sharp decline makes it difficult for the pair to regain its traction.
Gold aims to retest the $2,400 area
Gold advanced toward $2,400 on Wednesday as US Treasury bond yields pushed lower following the April inflation data. The recovery in US yields combined with the US Dollar's resilience after Jobless Claims data, however, causes XAU/USD to retreat toward $2,370 on Thursday.
Is the crypto bull run back? Premium
Bitcoin’s ascent to $65,000 seems to have breathed hope into the choppy crypto markets. Some altcoins have shot up 10% to 20% due to BTC’s comeback. Investors wonder if this is the resumption of the crypto bull run.
BRICS, the West and the rest – global trade hubs and de-dollarization
World trade is fragmenting into opposing blocks, warns the IMF. The BRICS and their allies are distancing themselves from the West. BRICS are attempting to de-dollarize and replace SWIFT to circumvent the threat of sanctions.